FILING ANALYSIS · FRIDAY, NOVEMBER 13
Beyond Air, Inc. XAIR — 8-K: Results of Operations and Financial Condition
neutral
The company reported record quarterly revenue of $2.3 million, a 28% year-over-year growth, and reaffirmed revenue guidance of $8 million for CY2026 and $16-$18 million for CY2027, with the second-generation LungFit PH system pending FDA approval.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →